Deutsche Bank’s ProPhase Labs PRPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,880
Closed -$56K 5349
2018
Q3
$56K Sell
1,880
-130
-6% -$3.92K ﹤0.01% 4686
2018
Q2
$65K Buy
+2,010
New +$66.5K ﹤0.01% 4697
2018
Q1
Sell
-1,865
Closed -$40K 5558
2017
Q4
$40K Buy
1,865
+419
+29% +$9.16K ﹤0.01% 4518
2017
Q3
$30K Buy
1,446
+1,197
+481% +$25.7K ﹤0.01% 4486
2017
Q2
$5K Buy
+249
New +$5K ﹤0.01% 4752
2016
Q3
Sell
-31
Closed 5140
2016
Q2
$0 Buy
+31
New +$418 ﹤0.01% 5307
2015
Q1
Sell
-131
Closed -$1K 5758
2014
Q4
$1K Buy
+131
New +$1.81K ﹤0.01% 6084
2014
Q2
Sell
-28
Closed 6012
2014
Q1
$0 Buy
+28
New +$531 ﹤0.01% 5744

Other funds holding PRPH

Deutsche Bank's PRPH Position: Q4 2018 in Review

Deutsche Bank sold out of ProPhase Labs (PRPH) in Q4 2018, closing a stake of 1,880 shares — an estimated $56K sold.

Deutsche Bank first reported a position in PRPH in Q1 2014 and held it in 8 quarters. The position peaked at $65K in Q2 2018. 14 funds tracked by Wall St. Rank hold PRPH as of Q4 2018.

  • Deutsche Bank reported no remaining ProPhase Labs position as of Q4 2018 after selling out during the quarter.
  • Deutsche Bank sold 1,880 ProPhase Labs shares in Q4 2018, an estimated $56K.
  • Deutsche Bank first reported a position in ProPhase Labs in Q1 2014 and held it in 8 quarters.
  • Deutsche Bank's ProPhase Labs position peaked at $65K in Q2 2018.
  • 14 funds tracked by Wall St. Rank held ProPhase Labs as of Q4 2018.

Based on Deutsche Bank's 13F filing for Q4 2018, filed 14 Feb 2019.